DK1000027T3 - Termodynamisk stabil modifikation af 1-(4-carbazolyloxy)-3-[2-(methoxyphenoxy)ethylamino]-2-propanol, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne - Google Patents
Termodynamisk stabil modifikation af 1-(4-carbazolyloxy)-3-[2-(methoxyphenoxy)ethylamino]-2-propanol, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denneInfo
- Publication number
- DK1000027T3 DK1000027T3 DK98937576T DK98937576T DK1000027T3 DK 1000027 T3 DK1000027 T3 DK 1000027T3 DK 98937576 T DK98937576 T DK 98937576T DK 98937576 T DK98937576 T DK 98937576T DK 1000027 T3 DK1000027 T3 DK 1000027T3
- Authority
- DK
- Denmark
- Prior art keywords
- carbazolyloxy
- methoxyphenoxy
- ethylamino
- propanol
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97112491A EP0893440A1 (en) | 1997-07-22 | 1997-07-22 | Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
| PCT/EP1998/004475 WO1999005105A1 (en) | 1997-07-22 | 1998-07-18 | Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1000027T3 true DK1000027T3 (da) | 2003-07-21 |
Family
ID=8227094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98937576T DK1000027T3 (da) | 1997-07-22 | 1998-07-18 | Termodynamisk stabil modifikation af 1-(4-carbazolyloxy)-3-[2-(methoxyphenoxy)ethylamino]-2-propanol, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne |
Country Status (31)
| Country | Link |
|---|---|
| EP (2) | EP0893440A1 (cs) |
| JP (1) | JP2001510824A (cs) |
| KR (1) | KR100336229B1 (cs) |
| CN (1) | CN1125047C (cs) |
| AR (1) | AR015133A1 (cs) |
| AT (1) | ATE236123T1 (cs) |
| AU (1) | AU740453B2 (cs) |
| BR (1) | BR9810776A (cs) |
| CA (1) | CA2296637C (cs) |
| CZ (1) | CZ296947B6 (cs) |
| DE (1) | DE69812964T2 (cs) |
| DK (1) | DK1000027T3 (cs) |
| ES (1) | ES2195366T3 (cs) |
| HR (1) | HRP980406A2 (cs) |
| HU (1) | HUP0003198A3 (cs) |
| IL (1) | IL133677A (cs) |
| MA (1) | MA26523A1 (cs) |
| MY (1) | MY117734A (cs) |
| NO (1) | NO313588B1 (cs) |
| NZ (1) | NZ502136A (cs) |
| PE (1) | PE96999A1 (cs) |
| PL (1) | PL191602B1 (cs) |
| PT (1) | PT1000027E (cs) |
| RU (1) | RU2202542C2 (cs) |
| SI (1) | SI1000027T1 (cs) |
| TR (1) | TR200000148T2 (cs) |
| TW (1) | TW505631B (cs) |
| UY (1) | UY25108A1 (cs) |
| WO (1) | WO1999005105A1 (cs) |
| YU (1) | YU2200A (cs) |
| ZA (1) | ZA986475B (cs) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001074356A1 (en) * | 2000-04-03 | 2001-10-11 | F. Hoffmann-La Roche Ag | Concentrated solutions of carvedilol |
| EP1655285A1 (en) * | 2000-06-28 | 2006-05-10 | Teva Pharmaceutical Industries Ltd. | Method for preparation of a crystalline form of carvedilol (form II) |
| WO2002000216A1 (en) | 2000-06-28 | 2002-01-03 | Teva Pharmaceutical Industries Ltd. | Carvedilol |
| AU2002326391A1 (en) * | 2001-07-13 | 2003-01-29 | Smithkline Beecham Corporation | Carvedilol polymorph |
| US20050019399A1 (en) | 2001-09-21 | 2005-01-27 | Gina Fischer | Controlled release solid dispersions |
| DE60221683T2 (de) * | 2001-09-28 | 2008-04-30 | F. Hoffmann-La Roche Ag | Pseudopolymorphe formen von carvedilol |
| EP1474133A4 (en) | 2002-01-15 | 2006-02-01 | Teva Pharma | SOLID CRYSTALLINE CARVEDILOL BODIES AND METHODS OF MAKING SAME |
| CA2483054A1 (en) * | 2002-04-30 | 2003-11-13 | Sb Pharmco Puerto Rico Inc. | Carvedilol monocitrate monohydrate |
| JP2005533822A (ja) * | 2002-06-27 | 2005-11-10 | エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド | 臭化水素酸カルベジロール |
| JP2005533823A (ja) | 2002-06-27 | 2005-11-10 | エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド | リン酸カルベジロール塩および／またはその溶媒和物、対応する組成物、および／または治療方法 |
| EP1562552A1 (en) | 2002-11-08 | 2005-08-17 | Egalet A/S | Controlled release carvedilol compositions |
| EP2301526B1 (en) | 2003-03-26 | 2016-03-23 | Egalet Ltd. | Morphine controlled release system |
| EP1615888A1 (en) * | 2003-04-21 | 2006-01-18 | Matrix Laboratories Ltd | Process for the preparation of carvedilol form-ii |
| SI21616A (sl) * | 2003-09-02 | 2005-04-30 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nove kristalne oblike karvedilola |
| EP1686986A4 (en) * | 2003-11-25 | 2009-05-27 | Sb Pharmco Inc | CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT |
| SI1838670T1 (sl) * | 2004-12-09 | 2010-04-30 | Zach System Spa | Postopek za pripravo karvedilola in njegovih entantiomer |
| KR20070088507A (ko) * | 2005-06-09 | 2007-08-29 | 테바 파마슈티컬 인더스트리즈 리미티드 | 카베딜올의 결정질 형태 및 이것의 제조 방법 |
| WO2008002683A2 (en) | 2006-06-28 | 2008-01-03 | Teva Pharmaceutical Industries Ltd. | Polymorphous forms of carvedilol phosphate |
| RU2366653C2 (ru) * | 2006-07-03 | 2009-09-10 | Ооо "Нанокриохимия" | Способ получения рентгеноаморфной модификации карведилола |
| US20080249317A1 (en) * | 2007-04-04 | 2008-10-09 | Apotex Inc. | Novel amorphous form of carvedilol phosphate and processes for the preparation thereof |
| WO2008148798A2 (en) | 2007-06-04 | 2008-12-11 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
| WO2010089132A1 (en) | 2009-02-06 | 2010-08-12 | Egalet A/S | Immediate release composition resistant to abuse by intake of alcohol |
| AU2010265213B2 (en) | 2009-06-24 | 2012-08-23 | Egalet Ltd. | Controlled release formulations |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2815926A1 (de) * | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE2805404A1 (de) * | 1978-02-09 | 1979-08-16 | Merck Patent Gmbh | 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung |
| DE3319027A1 (de) * | 1983-05-26 | 1984-11-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten |
-
1997
- 1997-07-22 EP EP97112491A patent/EP0893440A1/en not_active Withdrawn
-
1998
- 1998-07-15 PE PE1998000626A patent/PE96999A1/es not_active Application Discontinuation
- 1998-07-15 MY MYPI98003245A patent/MY117734A/en unknown
- 1998-07-18 IL IL13367798A patent/IL133677A/en not_active IP Right Cessation
- 1998-07-18 BR BR9810776-3A patent/BR9810776A/pt not_active Application Discontinuation
- 1998-07-18 CA CA002296637A patent/CA2296637C/en not_active Expired - Fee Related
- 1998-07-18 PT PT98937576T patent/PT1000027E/pt unknown
- 1998-07-18 CN CN98807436A patent/CN1125047C/zh not_active Expired - Fee Related
- 1998-07-18 CZ CZ20000221A patent/CZ296947B6/cs not_active IP Right Cessation
- 1998-07-18 AU AU86319/98A patent/AU740453B2/en not_active Ceased
- 1998-07-18 DE DE69812964T patent/DE69812964T2/de not_active Expired - Fee Related
- 1998-07-18 AT AT98937576T patent/ATE236123T1/de not_active IP Right Cessation
- 1998-07-18 WO PCT/EP1998/004475 patent/WO1999005105A1/en not_active Ceased
- 1998-07-18 DK DK98937576T patent/DK1000027T3/da active
- 1998-07-18 JP JP2000504104A patent/JP2001510824A/ja active Pending
- 1998-07-18 RU RU2000103033/04A patent/RU2202542C2/ru not_active IP Right Cessation
- 1998-07-18 TR TR2000/00148T patent/TR200000148T2/xx unknown
- 1998-07-18 TW TW087111738A patent/TW505631B/zh not_active IP Right Cessation
- 1998-07-18 KR KR1020007000667A patent/KR100336229B1/ko not_active Expired - Fee Related
- 1998-07-18 EP EP98937576A patent/EP1000027B1/en not_active Expired - Lifetime
- 1998-07-18 HU HU0003198A patent/HUP0003198A3/hu unknown
- 1998-07-18 SI SI9830442T patent/SI1000027T1/xx unknown
- 1998-07-18 NZ NZ502136A patent/NZ502136A/en unknown
- 1998-07-18 ES ES98937576T patent/ES2195366T3/es not_active Expired - Lifetime
- 1998-07-18 PL PL338432A patent/PL191602B1/pl unknown
- 1998-07-18 YU YU2200A patent/YU2200A/sh unknown
- 1998-07-20 MA MA25178A patent/MA26523A1/fr unknown
- 1998-07-21 ZA ZA9806475A patent/ZA986475B/xx unknown
- 1998-07-21 AR ARP980103547A patent/AR015133A1/es unknown
- 1998-07-22 UY UY25108A patent/UY25108A1/es not_active IP Right Cessation
- 1998-07-22 HR HR97112491.2A patent/HRP980406A2/hr not_active Application Discontinuation
-
2000
- 2000-01-21 NO NO20000301A patent/NO313588B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1000027T3 (da) | Termodynamisk stabil modifikation af 1-(4-carbazolyloxy)-3-[2-(methoxyphenoxy)ethylamino]-2-propanol, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne | |
| DK0780390T3 (da) | Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne | |
| DK1036794T3 (da) | 2-Aryl-8-oxodihydropurinderivater, fremgangsmåde til fremstilling af samme, medicinske præparater indeholdende samme og mellemprodukter deraf | |
| IS1850B (is) | Kristölluð a-fjölgervingsmynd af indól afleiðu, notkun hennar, aðferð til framleiðslu og lyfjaefnablanda | |
| DK1275387T3 (da) | Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed | |
| NO20005430L (no) | 1-[(1-substituerte-4-piperidinyl)metyl]-4-piperidinderivater, fremgangsmåter for fremstilling av disse, medisinske preparater inneholdende disse, og mellomprodukter for disse forbindelser | |
| DK0876131T3 (da) | Sammensætninger til lægemiddelindgivelse til forbedret stabilitet af androgener | |
| DK1156049T3 (da) | Substituerede heterocykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DK1053325T3 (da) | Tumorassocierede antigenderivater fra mage-familien og nukleinsyresekvenser, der koder for dem, anvendt til fremstilling af fusionsproteiner og præparater til vaccination | |
| HUP0400455A3 (en) | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function and pharmaceutical compositions containing them | |
| NO20015309D0 (no) | 1- (P-tienylbenzyl)-imidazoler som antiotensin-(1- 7)reseptoragonister, fremgangsmåte for fremstilling og anvendelseav de samme og farmasöytiske preparater som inneholder nevnteforbindelser | |
| DK0513543T3 (da) | Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og antikoagulationsmidler med indehold deraf | |
| DK0991654T3 (da) | Hidtil ukendte derivater af 2-(iminomethyl)aminophenyl, deres fremstilling, deres anvendelse til medikamenter og farmaceutiske præparater indeholdende samme | |
| DK1296948T3 (da) | N-gamma-krystallinsk form af perindopril-t-butylaminsalt, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dette | |
| DK0973763T3 (da) | Hidtil ukendte 2-(iminomethyl)aminophenylderivater, fremstilling af disse, anvendelse af disse i egenskab af lægemidler og farmaceutiske præparater indeholdende disse | |
| DK0885204T3 (da) | Nye arylglycinamidderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse forbindelser | |
| DK1089968T3 (da) | Thyroideahormonanaloger og fremgangsmåder til deres fremstilling | |
| DK0508220T3 (da) | Amidinophenylalaninderivater, fremgangsmåde til deres fremstiling, deres anvendelse og midler med in dhold deraf | |
| DK0783521T3 (da) | Polypeptidforbindelser indeholdende D-2-alkyltryptophan, hvilke er i stand til at fremme frigivelsen af væksthormon | |
| IL138825A0 (en) | Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them | |
| DK0975594T3 (da) | Fremgangsmåde til fremstilling af indolderivater | |
| DK1171444T3 (da) | Pyridothienodiazepiner, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse | |
| DK1165528T3 (da) | Hidtil ukendte morpholinoderivater, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse | |
| EE04437B1 (et) | (1-fenatsüül-3-fenüül-3-piperidinüületüül)piperidiini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
| NO20002114D0 (no) | Bicykliske forbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem |